Inactive Instrument
Artemis Therapeutics Inc Stock OTC Bulletin Board
Stocks
US04302Q1094
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Shimon Citron
CEO | Chief Executive Officer | 72 | 30/06/2022 |
David Dana
DFI | Director of Finance/CFO | 62 | 26/07/2022 |
Haim Tabak
COO | Chief Operating Officer | 78 | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Shimon Citron
BRD | Director/Board Member | 72 | 30/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 11.2K | ||
| +2.38% | +3.43% | +82.88% | +115.89% | 72.21B | ||
| +0.87% | +17.34% | +57.17% | +97.28% | 63.98B | ||
| -4.27% | -0.99% | -3.38% | +475.61% | 28.53B | ||
| -1.97% | +20.38% | -0.37% | +0.48% | 28.42B | ||
| +1.43% | +11.10% | +60.12% | +26.01% | 25.07B | ||
| -0.51% | +5.73% | +38.71% | -12.79% | 20.04B | ||
| -1.79% | -4.84% | +239.54% | +414.48% | 18.19B | ||
| +1.88% | +4.13% | +19.44% | +537.65% | 15.96B | ||
| -1.29% | +6.09% | +41.81% | +154.45% | 13.48B | ||
| Average | -0.39% | +5.49% | +59.55% | +201.01% | 31.76B | |
| Weighted average by Cap. | +0.15% | +7.70% | +59.64% | +163.62% |
Employees
-
















